Natco Pharma Limited — Others, 30-12-2024: Trading Window

NATCO Pharma has announced a board meeting to declare the financial results for the quarter ending December 31, 2024. In conjunction, the company will close its trading window for directors, designated persons, and connected individuals from January 1, 2025, until 48 hours after the results are announced. This strategic move aims to uphold the integrity of trading activities surrounding key financial disclosures. Investors may view this as a neutral impact, reflecting the company’s commitment to compliance while maintaining transparency in financial reporting, although it highlights the upcoming results as a focal point for market sentiment.